Global consensus statement on testosterone therapy for women: an Australian perspective

Christina Jang, Jacqueline A Boyle and Amanda Vincent
Med J Aust 2020; 213 (10): . || doi: 10.5694/mja2.50837
Published online: 2 November 2020

There is more to female sexual function than circulating testosterone, and symptomatic women require a thorough clinical evaluation

The 2019 global consensus position statement on the use of testosterone therapy for women1 aims to provide guidance for clinicians managing women with female sexual dysfunction. The recommendations, graded according to levels of evidence, have been developed by an international taskforce with representatives from a range of organisations and societies, headed by Australian endocrinologist Professor Susan Davis, the current President of the International Menopause Society. The position statement bases many of its recommendations on a systematic review and meta‐analysis of randomised controlled trials.2

  • Christina Jang1,2
  • Jacqueline A Boyle3,4
  • Amanda Vincent3,4

  • 1 Mater Health Services, Brisbane, QLD
  • 2 University of Queensland, Brisbane, QLD
  • 3 Monash Centre for Health Research and Implementation, Monash University, Melbourne, VIC
  • 4 Monash Health, Melbourne, VIC



This article has been reviewed and endorsed by the Endocrine Society of Australia, the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, and the Australasian Menopause Society.

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.